ReviewBiomarker research2019

Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphoma.

Amandeep Aujla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.